- GCV Symposium keynote interview: “As investors, we need… •
- GCV Symposium panel: Energy and Mobility •
- GCV Symposium fireside chat: Looking beyond the short… •
- GCV Symposium keynote: CVCs as change agents •
- Daily Deal Round Up: May 18, 2022 •
- Corporate venturing grows tepidly in April •
- Britain’s innovation space is stronger than ever despite… •
- Covid-19 drove more corporations to explore venture capital •
- Why do many Venture Capital Funded Start-ups shut… •
- Media sector still in the game after the… •
- Security provides the platform •
- Booming CVC is about to get a reality… •
Exit
Daily Deal Round Up: May 17, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 16, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 12, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 11, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 3, 2022
Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.
HilleVax racks up $200m in its IPO
The Takeda Vaccines spinoff floated in an upsized offering that granted its former parent $100m in shares.
Daily Deal Round Up: April 29, 2022
Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.
Daily Deal Round Up: April 28, 2022
Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.
Other News
Daily Deal Round Up: April 27, 2022
Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.
Daily Deal Round Up: April 26, 2022
Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.
GemPharmatech gets $175m in initial public offering
The Sinopharm-backed laboratory animal model developer floated on Shanghai Stock Exchange’s Star Market two years after its last equity funding.
Daily Deal Round Up: April 20, 2022
Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.
Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.
Daily Deal Round Up: April 19, 2022
Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.
Editor's Picks
Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.
Bolt ties on $1.5bn Wyre purchase
Kraken, OK Group, 9fBank and Baofoo are in line to exit Wyre, with its cryptocurrency infrastructure technology to strengthen Bolt's one-click checkout offering.
Fast hits the wall
The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.
GoTo gets $1.1bn in initial public offering
The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.
About us
Global Corporate Venturing (GCV) is where global innovation and capital converge to define, invest and shape the world of tomorrow. We provide the world’s investors and the wider innovation ecosystem with the information, insights, collaboration and access they need to succeed in a constantly changing world.
Navigation
